Product
PXS-5505
1 clinical trial
1 indication
Indication
MyelofibrosisClinical trial
A Phase 1/2a Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Postpolycythemia Vera or Post-essential Thrombocythemia MyelofibrosisStatus: Recruiting, Estimated PCD: 2025-08-01